William Richard White - 09 Nov 2023 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
Chief Financial Officer
Signature
/s/ William White
Issuer symbol
AKRO
Transactions as of
09 Nov 2023
Net transactions value
$0
Form type
4
Filing time
13 Nov 2023, 17:37:20 UTC
Previous filing
25 Sep 2023
Next filing
12 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKRO Stock Option (Right to Buy) Award $0 +83,400 $0.000000 83,400 09 Nov 2023 Common Stock 83,400 $14.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 33% of the shares subject to this option shall vest and become exercisable on November 9, 2024, with the remainder vesting in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.